Modern Clinical Guidelines for the Management of Patients with Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is a chronic condition with recurrent retrograde flow of gastric contents to esophagus due to impaired lower esophageal sphincter function. It leads to typical symptoms such as heartburn, regurgitation, and dysphagia, as well as non-specific manifestations such as cough, sore throat, retrosternal pain. Implementation of modern diagnostic methods and personalized therapeutic strategies can significantly reduce symptoms, prevent complications, and improve quality of life of patients with GERD. The presented clinical guidelines describe integrated approach to diagnosis including history taking, physical examination, and imaging studies. Differential diagnosis with other diseases with similar symptoms is crucial as well. GERD management should be systemic and include non-pharmacological measures: lifestyle correction and drug therapy (antacids, proton pump inhibitors, and prokinetics). Particular attention is paid to complications prevention. These guidelines are the basis for timely and comprehensive management for GERD patients.

1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900– 1920; quiz 1943. doi: https://doi.org/10.1111/j.15720241.2006.00630.x

2. Ivashkin VT, Maev IV, Trukhmanov AS, et al. Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(4):70–97. (In Russ). doi: https://doi.org/10.22416/1382-4376-2020-30-470-97

3. Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a metaanalysis. Gut. 2018;67(3):430–440. doi: https://doi.org/10.1136/gutjnl-2016-313589

4. Lazebnik LB, Masharova AA, Bordin DS, et al. Results of a multicenter trial “Epidemiology of Gastroesophageal Reflux Disease in Russia” (MEGRE). Terapevticheskii arkhiv. 2011;83(1):45–50. (In Russ).

5. Zagorskiĭ SÈ, Korzhik AV, Fursa TIu, Pechkovskaia EV. Epidemiological aspects of gastroesophageal reflux disease in children in the conditions of large industrial city. Eksp Klin Gastroenterol. 2013:(5);17–22.

6. Gilger MA, El-Serag HB, Gold BD, et al. Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study. J Pediatr Gastroenterol Nutr. 2008;47(2):141–146. doi: https://doi.org/10.1097/MPG.0b013e31815eeabe

7. Gonzalez Ayerbe JI, Hauser B, Salvatore S, Vandenplas Y. Diagnosis and management of gastroesophageal reflux disease in infants and children: From guidelines to clinical practice. Pediatr Gastroenterol Hepatol Nutr. 2019;22(2):107–121. doi: https://doi.org/110.5223/pghn.2019.22.2.107

8. Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol. 2009;104(5):1278–1295; quiz 1296. doi: https://doi.org/10.1038/ajg.2009.129

9. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172–180. doi: https://doi.org/10.1136/gut.45.2.172

10. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111(1):85–92. doi: https://doi.org/10.1053/gast.1996.v111.pm8698230

11. Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(3):516–554. doi: https://doi.org/10.1097/MPG.0000000000001889

12. Krugmann J, Neumann H, Vieth M, Armstrong D. What is the role of endoscopy and oesophageal biopsies in the management of GERD? Best Pract Res Clin Gastroenterol. 2013;27(3):373–385. doi: https://doi.org/10.1016/j.bpg.2013.06.010

13. Privorotskii VF, Luppova NE. Gastroezofageal’gnaya reflyuksnaya bolezn’ u detei: Textbook. St. Petersburg: Costa; 2015. 75 p. (In Russ).

14. Bolezni pishchevoda u detei. Bel’mer SV, Razumovskiy AYu, Privorotskiy VF, Khavkin AI. Moscow: ID “Medpraktika-M”; 2016. 316 s. (In Russ).

15. GERD. Global Perspective on Gastroesophageal Reflux Disease: World Gastroenterology Organisation. Global Guidelines World Gastroenterology Organisation; 2015. (In Russ). Available online: https://www.worldgastroenterology.org/UserFiles/file/guidelines/gastroesophageal-reflux-disease-russian-2015.pdf. Accessed on November 30, 2025.

16. Espinheira M, Dias J. Management of gastroesophageal reflux in pediatrics. Pediatrics. Consilium Medicum. 2018;(3):16–23. (In Russ). doi: https://doi.org/10.26442/2413-8460_2018.3.16-23

17. Niu X, Wu ZH, Xiao XY, Chen X. The relationship between adenoid hypertrophy and gastroesophageal reflux disease: A metaanalysis. Medicine (Baltimore). 2018;97(41):e12540. doi: https://doi.org/10.1097/MD.0000000000012540

18. Belan EB, Sadchikova TL, Panina AA, et al. Optimizatsiya terapii retsidiviruyushchego rinofaringita, assotsiirovannogo s tsitomegalovirusom ili virusom Epshteina–Barr, u detei. Pharmateca. 2015;(14):63–66. (In Russ).

19. Shul’zhenko AE, Zuikova IN, Shchubelko RV. Issues of treatment and prevention of recurrent inflammatory diseases of the upper respiratory tract: An immunologist’s view. A review. Terapevticheskii Arkhiv. 2024;96(11):1076–1082. doi: https://doi.org/10.26442/00403660.2024.11.203033

20. Vandenplas Y, Hauser B, Salvatore S. Diagnosis and management of gastroesophageal reflux disease in infants and children: from guidelines to clinical practice. Pediatrics. Consilium Medicum. 2019;(3):14–23. (In Russ). doi: https://doi.org/10.26442/26586630.2019.3.190438

21. Detskaya gastroenterologiya: National leadership. Belmer SV, Khavkin AI, eds. Moscow: GEOTAR-Media; 2022. pp. 110–158. (In Russ).

22. Hyams JS, Ricci A Jr, Leichtner AM. Clinical and laboratory correlates of esophagitis in young children. J Pediatr Gastroenterol Nutr. 1988;7(1):52. doi: https://doi.org/10.1097/00005176198801000-00011

23. Valusek PA, St Peter SD, Keckler SJ, et al. Does an upper gastrointestinal study change operative management for gastroesophageal reflux? J Pediatr Surg. 2010;45(6):1169–1172. doi: https://doi.org/10.1016/j.jpedsurg.2010.02.083

24. Detskaya endoskopiya: Methodological recommendations. Korolev MP, ed. St. Petersburg: Russian Endoscopic Society; 2020. 112 p. (In Russ).

25. Scherbakov PL, Zablodsky AN. Gastroesophageal reflux disease in children: the role of endoscopy. Eksperimental’naya i Klinicheskaya Gastroenterologiya. 2014;(1):66–73. (In Russ).

26. Zhang NN, Ma YM, Sun Q, et al. Evaluation of Minimal Change Lesions Using Linked Color Imaging in Patients With Nonerosive Reflux Esophagitis. J Clin Gastroenterol. 2022;56(5):405–411. doi: https://doi.org/10.1097/MCG.0000000000001538

27. Deng P, Min M, Dong T, et al. Linked color imaging improves detection of minimal change esophagitis in non-erosive reflux esophagitis patients. Endosc Int Open. 2018;6(10):E1177–E1183. doi: https://doi.org/10.1055/a-0602-3997

28. Shiotani A, Kasugai K. Pharynx and esophagus: Esophageal benign diseases. Dig Endosc. 2022;34(Suppl 2):31–35. doi: https://doi.org/10.1111/den.14109

29. Thomson M, Tringali A, Dumonceau JM, et al. Paediatric Gastrointestinal Endoscopy: European Society for Paediatric Gastroenterology Hepatology and Nutrition and European Society of Gastrointestinal Endoscopy Guidelines. J Pediatr Gastroenterol Nutr. 2017;64(1):133–153. doi: https://doi.org/10.1097/MPG.0000000000001408

30. Raicevic M, Saxena AK. Barrett’s esophagus in children: what is the evidence? World J Pediatr. 2018;14(4):330–334. doi: https://doi.org/10.1007/s12519-018-0170-6

31. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392– 1399. doi: https://doi.org/10.1053/j.gastro.2006.08.032

32. Sugano K, Spechler SJ, El-Omar EM, et al. Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction. Gut. 2022;71(8):1488–1514. doi: https://doi.org/10.1136/gutjnl-2022-327281

33. Rentgenologicheskoe issledovanie organov pishchevaritel’nogo trakta u detei: Methodological recommendations. Moscow: USSR Ministry of Health; 1981. (In Russ).

34. Tager IL, Filippkin MA. Rentgenodiagnostika zabolevanii organov pishchevareniya u detei. Moscow: Meditsina; 1974. 287 p. (In Russ).]

35. Levine MD, Korshun Z, Mendelson G. Pathological physiology of gastroesophageal reflux disease. Hypothesis (Review). Eksperimental’naya i Klinicheskaya Gastroenterologiya. 2013;(5):72–88. (In Russ).

36. Rimashevskii VB. Sposob diagnostiki gastroezofageal’noi reflyuksnoi bolezni. In: Aktual’nye voprosy diagnostiki, lecheniya i reabilitatsii bol’nykh: Abstract book of the regional scientific and practical conference. Grodno; 2012. pp. 106–108. (In Russ).

37. Winter HS. Gastroesophageal reflux in infants. In: UpToDate. Feb 18, 2025. Available online: https://www.uptodate.com/contents/gastroesophageal-reflux-in-infants?source=history#H507464716. Accessed on November 30, 2025.

38. Alkhasov AB, Razumovskii AYu, Kucherov YuI, Bataev SM. Sutochnyi pH-monitoring pishchevoda v diagnostike gastroezofageal’nogo reflyuksa u detei. Detskaya khirurgiya = Russian Journal of Pediatric Surgery. 2000;(1):47–50. (In Russ).

39. Vandenplas Y, Salvatore S, Devreker T, Hauser B. Gastrooesophageal reflux disease: oesophageal impedance versus pH monitoring. Acta Paediatr. 2007;96(7):956–962. doi: https://doi.org/10.1111/j.1651-2227.2007.00306.x

40. Johnson LF, Demeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974;62(4):325–332.

41. Boix-Ochoa J, Lafuenta JM, Gil-Vernet JM. Twenty-four hour exophageal pH monitoring in gastroesophageal reflux. J Pediatr Surg. 1980;15(1):74–78. doi: https://doi.org/10.1016/s00223468(80)80407-6

42. Stepanyan MJu, Komarova EV, Lohmatov MM, Gordeeva IG. Mano-Impedancemetric Diagnosis of Esophageal Function in Children With Dyspepsia. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2018;15(5):402–409. (In Russ). doi: https://doi.org/10.15690/pf.v15i5.1963

43. Hsing TY, Tsai IJ, Hsu CT, Wu JF. Role of esophageal manometry in children with refractory gastroesophageal reflux symptoms. Pediatr Int. 2019;61(8):807–811. doi: https://doi.org/10.1111/ped.13917

44. Aruin LI, Isakov VA. Gastroezofageal’naya reflyuksnaya bolezn’ i Helicobacter pylori. Clinical Medicine (Russian Jornal). 2000;78(10):62–68. (In Russ).

45. Programma optimizatsii vskarmlivaniya detei pervogo goda zhizni v Rossiiskoi Federatsii: Methodological recommendations. Moscow; 2019. (In Russ).

46. Zeevenhooven J, Koppen IJ, Benninga MA. The New Rome IV Criteria for Functional Gastrointestinal Disorders in Infants and Toddlers. Pediatr Gastroenterol Hepatol Nutr. 2017;20(1):1–13. doi: https://doi.org/10.5223/pghn.2017.20.1.1

47. Pados BF, Basler A. Gastrointestinal Symptoms in Healthy, FullTerm Infants Under 7 Months of Age. J Pediatr Nurs. 2020;53:1–5. doi: https://doi.org/10.1016/j.pedn.2020.03.011

48. Younes M, Aquilina G, Castle L, et al. Re-evaluation of locust bean gum (E 410) as a food additive in foods for infants below 16 weeks of age and follow-up of its re-evaluation as a food additive for uses in foods for all population groups EFSA Panel on Food Additives and Flavourings (FAF). EFSA J. 2023;21(2):e07775. doi: https://doi.org/10.2903/j.efsa.2023.7775

49. Salvatore S, Savino F, Singendonk M, et al. Thickened infant formula: What to know. Nutrition. 2018;49:51–56. doi: https://doi.org/10.1016/j.nut.2017.10.010

50. Meunier L, Garthoff JA, Schaafsma A, et al. Locust bean gum safety in neonates and young infants: an integrated review of the toxicological database and clinical evidence. Regul Toxicol Pharmacol. 2014;70(1):155–169. doi: https://doi.org/10.1016/j.yrtph.2014.06.023

51. Salvatore S, Klymenko V, Karpushenko Y, et al. Tolerance and safety of an anti-regurgitation formula containing locust bean gum, preand postbiotics: an international multicenter prospective randomized controlled trial in infants with regurgitation. Nutrients. 2024;16(6):899. doi: https://doi.org/10.3390/nu16060899

52. Bellaiche M, Ludwig T, Arciszewska M, et al., Safety and Tolerance of a Novel Anti-Regurgitation Formula: A DoubleBlind, Randomised, Controlled Trial. J Pediatr Gastroenterol Nutr. 2021;73(5):579–585. doi: https://doi.org/10.1097/MPG.0000000000003289

53. Bellaiche M, Tounian P, Oozeer R, et al. Digestive Tolerance and Safety of an Anti-Regurgitation Formula Containing Locust Bean Gum, Prebiotics and Postbiotics: A Real-World Study. Pediatr Gastroenterol Hepatol Nutr. 2023;26(5):249–265. doi: https://doi.org/10.5223/pghn.2023.26.5.249

54. Kwok TC, Ojha S, Dorling J. Feed thickener for infants up to six months of age with gastro-oesophageal reflux. Cochrane Database Syst Rev. 2017;12(12):CD003211. doi: https://doi.org/10.1002/14651858.CD003211.pub2

55. Chevalier I, Beck CE, Doré-Bergeron MJ, Orkin J. Medical management of gastro-esophageal reflux in healthy infants. Paediatr Child Health. 2022;27(8):503–511. doi: https://doi.org/10.1093/pch/pxac068.

56. Orenstein SR, Hassall E, Furmaga-Jablonska W, et al. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154(4):514–520.e4. doi: https://doi.org/10.1016/j.jpeds.2008.09.054

57. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr. 2007;150(3):262–267, 267.e1. doi: https://doi.org/10.1016/j.jpeds.2006.08.078

58. Golubeva VV. Non-medicamental methods for the treatment of the patients presenting with gastroesophageal reflux disease. Russian Journal of Physiotherapy, Balneology and Rehabilitation. 2013;(5):10–14. (In Russ).

59. Tighe M, Afzal NA, Bevan A, et al. Pharmacological treatment of children with gastro-oesophageal reflux. Cochrane Database Syst Rev. 2014;2014(11):CD008550. doi: https://doi.org/10.1002/14651858.CD008550.pub2

60. Scally B, Emberson JR, Spata E, et al. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomized trials. Lancet Gastroenterol Hepatol. 2018;3(4):231–241. doi: https://doi.org/10.1016/S2468-1253(18)30037-2

61. Hu ZH, Shi AM, Hu DM, Bao JJ. Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trial. Saudi J Gastroenterol. 2017;23(1):11–19. doi: https://doi.org/10.4103/1319-3767.199117

62. Jimenez J, Drees M, Loveridge-Lenza B, et al. Exposure to Gastric Acid-Suppression Therapy Is Associated With Health Careand Community-Associated Clostridium difficile Infection in Children. J Pediatr Gastroenterol Nutr. 2015;61(2):208–211. doi: https://doi.org/10.1097/MPG.0000000000000790

63. Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and communityacquired pneumonia in children. Pediatrics. 2006;117(5):e817– e820. doi: https://doi.org/10.1542/peds.2005-1655

64. Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, et al. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Ren Fail. 2015;37(7):1237–1241. doi: https://doi.org/10.3109/0886022X.2015.1057800

65. Shumilov PV, Khavkin AI, Kucheryavy YuA, et al. Evaluation of esophagoprotective therapy for gastroesophageal reflux disease with extraesophageal symptoms in children and adolescents: results of an open-label, multicenter, observational study. Voprosy detskoi dietologii = Pediatric Nutrition. 2022;20(6):5–13. (In Russ). doi: https://doi.org/10.20953/17275784-2022-6-5-13

66. Ipatova MG. Esophagoprotection in the Treatment of Gastroesophageal Reflux Disease in Children. Effektivnaya farmakoterapiya. 2022;18(50):8–14. (In Russ). doi: https://doi.org/10.33978/2307-3586-2022-1850-8-14

67. Palmieri B, Corbascio D, Capone S, Lodi D. Preliminary clinical experience with a new natural compound in the treatment of esophagitis and gastritis: symptomatic effect. Trends Med. 2009;9(4):219–225.

68. Sheptulin AA, Kurbatova AA, Baranov SA. Modern options of prokinetics in gastroesophageal reflux disease treatment. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):71–77. (In Russ). doi: https://doi.org/10.22416/1382-4376-2018-28-1-71-77

69. Sintusek P, Mutalib M, Thapar N. Gastroesophageal reflux disease in children: What’s new right now? World J Gastrointest Endosc. 2023;15(3):84–102. doi: https://doi.org/10.4253/wjge.v15.i3.84

70. Winter HS. Gastroesophageal reflux disease in children and adolescents: Management. In: UpToDate. Jan 22, 2024. Available online: https://www.uptodate.com/contents/management-of-gastroesophageal-reflux-disease-in-children-and-adolescents?source=history_widget#H10. Accessed on November 30, 2025.

71. Moon A, Solomon A, Beneck D, Cunningham-Rundles S. Positive association between Helicobacter pylori and gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 2009;49(3):283238. doi: https://doi.org/10.1097/MPG.0b013e31818eb8de

72. Lupu VV, Beşer ÖF, Gurzu S, et al. Pediatric Gastroenterology Research. Life (Basel). 2023;13(9):1810. doi: https://doi.org/10.3390/life13091810

73. Horgan S, Pellefrini CA. Surgical treatment of gastroesophageal reflux disease. Surg Clin North Am. 1997;77(5):1063–1082. doi: https://doi.org/10.1016/s0039-6109(05)70605-8

74. Detskaya gastroenterologiya: natsional’noe rukovodstvo. Kratkoe izdanie. Belmer SV, Razumovskiy AYu, Khavkin AI, eds. Moscow: GEOTARMedia; 2024. 688 p. (In Russ).

75. Razumovskii AYu, Alkhasov AB. Khirurgicheskoe lechenie gastroezofageal’nogo reflyuksa u detei: A guide for doctors. Moscow: GEOTAR-Media; 2010. 200 p. (In Russ).

76. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49(4):498–547. doi: https://doi.org/10.1097/MPG.0b013e3181b7f563

77. Razumosky AY, Alhasov AB, Bataev SHM, Yekimovskaya EV. Laparoscopic fundoplication nissen — gold standard treatment of gastroesophageal reflux in children. Eksperimental’naya i Klinicheskaya Gastroenterologiya. 2015;(1):72–77. (In Russ).

78. Razumovskij AYu, Ekimovskaya EV. Aspects of surgical treatment of gastroesophageal reflux relapse in children and teens. Pirogov Russian Journal of Surgery. 2014;(6):77–80. (In Russ).

79. Rothenberg SS. Two decades of experience with laparoscopic nissen fundoplication in infants and children: a critical evaluation of indications, technique, and results. J Laparoendosc Adv Surg Tech A. 2013;23(9):791–794. doi: https://doi.org/10.1089/lap.2013.0299

80. Hambraeus M, Arnbjornsson E, Anderberg M. A literature review of the outcomes after robot-assisted laparoscopic and conventional laparoscopic Nissen fundoplication for gastro-esophageal reflux disease in children. Int J Med Robot. 2013;9(4):428–432. doi: https://doi.org/10.1002/rcs.1517

81. Killaars REM, Mollema O, Cakir H, et al. Robotic-Assisted Nissen Fundoplication in Pediatric Patients: A Matched Cohort Study. Children (Basel). 2024;11(1):112. doi: https://doi.org/10.3390/children11010112

82. Stefanidis D, Hope WW, Kohn GP, et al. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24(11):2647–2669. doi: https://doi.org/10.1007/s00464-010-1267-8

83. Moore M, Afaneh C, Benhuri D, et al. Gastroesophageal reflux disease: A review of surgical decision making. World J Gastrointest Surg. 2016;8(1):77–83. doi: https://doi.org/10.4240/wjgs.v8.i1.77

84. Razumovsky AYu, Ekimovskaya EV, Alkhatov AB, et al. Recurrent gastroesophageal reflux in children after laparoscopic fundoplication: modified operation and analysis of risk factors. Detskaya khirurgiya = Russian Journal of Pediatric Surgery. 2015;19(1):4–8. (In Russ).

85. Razumovsky AYu, Alkhasov AB, Bataev S-KhM, Ekimovskaya EV. Repeated surgical interventions on the children with gastroesophageal reflux. Detskaya khirurgiya = Russian Journal of Pediatric Surgery. 2014;18(4):4–8. (In Russ).

86. Maret-Ouda J, Konings P, Lagergren J, et al. Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis. Ann Surg. 2016;263(2):251–257. doi: https://doi.org/10.1097/SLA.0000000000001438

87. Kubiak R, Andrews J, Grant HW. Long-term outcome of laparoscopic nissen fundoplication compared with laparoscopic thal fundoplication in children: a prospective, randomized study. Ann Surg. 2011;253(1):44–49. doi: https://doi.org/10.1097/sLA.0b013e3181fc98a0

88. Smith CD, McClusky DA, Rajad MA, et al. When fundoplication fails: redo? Ann Surg. 2005;241(6):861–869. doi: https://doi.org/10.1097/01.sla.0000165198.29398.4b

89. Pascoe E, Falvey T, Jiwane A, et al. Outcomes of fundoplication for paediatric gastroesophageal reflux disease. Pediatr Surg Int. 2016;32(4):353–361. doi: https://doi.org/10.1007/s00383-015-3843-4

90. Razumovsky AYu, Alkhasov AВ, Kulikova NV, et al. Lowinvasive surgery of gastroesophageal reflux in children. Detskaya khirurgiya = Russian Journal of Pediatric Surgery. 2006;(3):9–12. (In Russ).

91. Kellokumpu I, Voutilainen M, Haglund C, et al. Quality of life following laparoscopic Nissen fundoplication: assessing short-term and long-term outcomes. World J Gastroenterol. 2013;19(24):3810– 3818. doi: https://doi.org/10.3748/wjg.v19.i24.3810

92. Davis CS, Baldea A, Johns JR, et al. The evolution and longterm results of laparoscopic antireflux surgery for the treatment of gastroesophageal reflux disease. JSLS. 2010;14(3):332–341. doi: https://doi.org/10.4293/108680810X12924466007007

93. Wakeman DS, Wilson NA, Warner BW. Current status of surgical management of gastroesophageal reflux in children. Curr Opin Pediatr. 2016;28(3):356–362. doi: https://doi.org/10.1097/MOP.0000000000000341

94. Mauritz FA, van Herwaarden-Lindeboom MY, Stomp W, et al. The effects and efficacy of antireflux surgery in children with gastroesophageal reflux disease: a systematic review. J Gastrointest Surg. 2011;15(10):1872–1878. doi: https://doi.org/10.1007/s11605-011-1644-1

95. Mauritz FA, Conchillo JM, van Heurn LW, et al. Effects and efficacy of laparoscopic fundoplication in children with GERD: a prospective, multicenter study. Surg Endosc. 2017;31(3):1101– 1110. doi: https://doi.org/10.1007/s00464-016-5070-z

96. Baerg J, Thorpe D, Bultron G, et al. A multicenter study of the incidence and factors associated with redo Nissen fundoplication in children. J Pediatr Surg. 2013;48(6):1306–1311. doi: https://doi.org/10.1016/j.jpedsurg.2013.03.028

97. Srivastava R, Berry JG, Hall M, et al. Reflux related hospital admissions after fundoplication in children with neurological impairment: retrospective cohort study. BMJ. 2009;339:b4411. doi: https://doi.org/10.1136/bmj.b4411

98. Esposito C, Saxena A, Irtan S, et al. Laparoscopic Nissen Fundoplication: An Excellent Treatment of GERD-Related Respiratory Symptoms in Children-Results of a Multicentric Study. J Laparoendosc Adv Surg Tech A. 2018;28(8):1023–1028. doi: https://doi.org/10.1089/lap.2017.0631

99. Aumar M, Lalanne A, Guimber D, et al. Influence of Percutaneous Endoscopic Gastrostomy on Gastroesophageal Reflux Disease in Children. J Pediatr. 2018;197:116. doi: https://doi.org/10.1016/j.jpeds.2018.02.003

100. Barnhart DC, Hall M, Mahant S, et al. Effectiveness of fundoplication at the time of gastrostomy in infants with neurological impairment. JAMA Pediatr. 2013;167(10):911–918. doi: https://doi.org/10.1001/jamapediatrics.2013.334

101. Yap BK, Nah SA, Chen Y, Low Y. Fundoplication with gastrostomy vs gastrostomy alone: a systematic review and meta-analysis of outcomes and complications. Pediatr Surg Int. 2017;33(2):217–228. doi: https://doi.org/10.1007/s00383-016-4028-5

102. Sulaeman E, Udall JN Jr, Brown RF, et al. Gastroesophageal reflux and Nissen fundoplication following percutaneous endoscopic gastrostomy in children. J Pediatr Gastroenterol Nutr. 1998;26(3):269–273. doi: https://doi.org/10.1097/00005176-199803000-00006

103. Broekaert IJ, Falconer J, Bronsky J, et al. The Use of Jejunal Tube Feeding in Children: A Position Paper by the Gastroenterology and Nutrition Committees of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition 2019. J Pediatr Gastroenterol Nutr. 2019;69(2):239–258. doi: https://doi.org/10.1097/MPG.0000000000002379

104. Goodman CC, Fuller KS. Pathology: Implications for the Physical Therapist. 3rd edn. St. Louis: Saunders Elsevier; 2009.

105. Belmer SV, Privorotskii VF. Gastroezofageal’naya reflyuksnaya bolezn’ u detei: otechestvennyi rabochii protokol 2013 goda. Lechaschi Vrach. 2013;(8):66–71. (In Russ).

106. U.S. National Library of Medicine — The World’s Largest Medical Library. A.D.A.M. Medical Encyclopedia. Gastroesophageal reflux disease. Available online: https://web.archive.org/web/20140104160640/http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001311. Accessed on November 29, 2025.

107. Padwal T, Gurudut P, Hajare S. Effect of shakers exercise with kinesio taping in subjects with gastroesophageal reflux disease: A randomized controlled trial. Int J Med Res Health Sci. 2016;5(10):170–178.

108. Butorina NV, Vakhrushev JaM. Evaluation of the effectiveness of comprehensive treatment strategies in the management of patients with gastroesophageal reflux disease including balneotherapy and rehabilitation in sanatoriums and health-resortsn. Kremlevskaya meditsina. Klinicheskii vestnik. (In Russ). doi: https://doi.org/10.48612/cgma/m6pu-b2xb-nhbe

109. Agasarov LG, Andronov SV, Apkhanova TV, et al. Sanatorno-kurortnoe lechenie: Scientific and practical guide for doctors: in 2 vol. Rachin AP, Yakovlev MYu, sci. eds. Moscow: Renovatsiya; 2022. (In Russ).

110. Tounian P, Meunier L, Speijers G, et al. Effectiveness and tolerance of a locust bean gum thickened formula: a real-life study. Pediatr Gastroenterol Hepatol Nutr. 2020;23(6):511–520. doi: https://doi.org/10.5223/pghn.2020.23.6.511